Jefferies lowered the firm’s price target on Progyny (PGNY) to $19 from $24 and keeps a Buy rating on the shares. The firm is lowering estimates to reflect selling season results – 1.1M member adds offset by about 700,000 from a previously announced customer loss – while also taking “a more conservative approach” to modeling utilization/mix in Q4 and FY25.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks